Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roche Holding AG Basel American Depositary Shares (OP: RHHBY ) 39.27 -0.07 (-0.18%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,642,611 Open 39.21 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 39.34 Today's Range 39.11 - 39.36 52wk Range 29.20 - 40.20 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review July 19, 2024 The Nasdaq tumbled amid chip woes. Via Investor's Business Daily EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' July 18, 2024 Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. Via Benzinga Performance YTD +8.03% +8.03% 1 Month +11.50% +11.50% 3 Month +29.14% +29.14% 6 Month +11.12% +11.12% 1 Year -0.56% -0.56% More News Read More VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday? July 18, 2024 Via Benzinga Topics Stocks Exposures US Equities New Data for Genentech’s Susvimo Demonstrates Sustained Efficacy in Two Serious Diabetic Eye Conditions July 18, 2024 From Genentech Via Business Wire Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped July 17, 2024 Via The Motley Fool Genentech’s Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term Diabetic Macular Edema (DME) Study July 17, 2024 From Genentech Via Business Wire Pfizer And Roche Advance On Their Weight Loss Drug Journeys July 17, 2024 Via Benzinga Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? July 17, 2024 Via Benzinga Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study July 17, 2024 Via Benzinga Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity July 17, 2024 From Genentech Via Business Wire Genentech to Reintroduce Susvimo for People With Wet Age-related Macular Degeneration (AMD) July 08, 2024 From Genentech Via Business Wire 3 Small-Cap Stocks With Explosive 2X Growth Potential July 08, 2024 Via InvestorPlace Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients July 05, 2024 Via Benzinga FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss July 05, 2024 From Genentech Via Business Wire Genentech Provides Update on Phase II/III SKYSCRAPER-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer July 04, 2024 From Genentech Via Business Wire AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway June 27, 2024 Via Benzinga Exposures Product Safety Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case June 24, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments June 21, 2024 Via Benzinga Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost June 21, 2024 Via InvestorPlace Exposures Product Safety FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy June 21, 2024 Via Benzinga Exposures Product Safety Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 Via FinancialNewsMedia Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 From FN Media Group LLC Via GlobeNewswire Alzheimer's Drug Stocks: Investing in Eli Lilly, Biogen, Roche June 19, 2024 Via MarketBeat Exposures Product Safety Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma June 15, 2024 From Genentech Via Business Wire Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win June 11, 2024 Via Investor's Business Daily Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
